7/21/2014 National Institute of Standards and Technology (NIST) Quantitative Imaging Initiatives Stephen Russek Project Leader: Biomagnetic Imaging Standards, NIST, Boulder, CO NIST Boulder F2 time standard NIST Gaithersburg Josephson junction voltage standard AAPM MO-C-12A-6 July 21, 2014 Outline 1. Role of NIST 2. NIST Medical Imaging Standards: what's new • Ionizing radiation standards (Radiation Physics Division) CT / PET phantoms • Optical imaging standards • Computational standards (Information Technology Lab) Virtual/ numerical phantoms 3. MRI standards/ phantoms (Electromagnetics Division) • • • NIST/ISMRM MRI system phantom NIST/USCF breast phantom NIST/RSNA QIBA isotropic diffusion phantom (Mike Boss TU-C-12A-8 Tuesday 10:15AM) NIST’s Role in Quantitative Medical Imaging NIST is a National Metrology Institute: measurement & standards We are good at: • • • • • • Standard reference materials (SRMs) Standard reference artifacts (phantoms) Enabling traceability Establishment of “ground truth” Long term monitoring Measurement development/ basic metrology research Not good at: • Setting standards, most standards are consensus • Phantom mass production • Moving very fast Universities NIH NIST Clinical Sites Pharma FDA Professional Societies Venders 1 7/21/2014 Evolution of NIST medical imaging standards Safety based standards NIST radiation dose standards Imaging as quantitative measurement of biomarkers Mammography Quality Standards Act NIST Metrology PET/CT & MRI 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010 Imaging as a Biomarker: Standards for Change Measurements in Therapy Workshop Summary September 14-16, 2006,Laurence Clarke Ram D. Sriram NISTIR 7434 Congressionally funded NIST imaging initiatives Patient Protection and Affordable Care Act Metrology for Computed Tomography (CT) • • • Calorimetry-based dosimetry (MO-E-17A-12) SRMs with calibrated attenuation coefficients Simple dimensional phantoms Foam lung mimics SRM 2087 Dimensional Standard for Medical Computed Tomography SRM 2088 Density Standard for Medical Computed Tomography Heather Chen-Mayer at the PET/CT scanner with HDPE phantoms. Z.H. Levine standards standards Brian Zimmerman 2 7/21/2014 Brian Zimmerman PET Phantoms 68Ge in epoxy cylinders Brian Zimmerman • Monitor scanner performance during clinical trials • Comparison across scanners and clinical sites • Accuracy of reconstruction and scatter/attenuation corrections Standard uncertainty on activity ~ 1 % Compatible with Jaczszak or ACR IQ phantoms Optical Medical Imaging Program at NIST Jeeseong Hwang, David Allen, Toni Litorja (PML) Antonio Possolo (ITL) Emerging Application Areas: Calibrated Hyperspectral imaging: ( surgery, combat and diabetic wounds) “Wet” and digital phantoms [HbO2]/[Hb] Tissue Oximetric Imaging imaging with a palette of 100s of contiguous spectral bands. Each pixel has a full spectrum and can reveal chemical information about a region. Optical coherence tomography: Near-IR 3d imaging technique that collects scattered light that reveals sub-surface features, 1mm resolution Fast tunable white light laser source *instrument is currently in demo mode NIST Workshop on “Standards for the Advancement of Optical Medical Imaging,” August 26-27, 2014 NIST Gaithersburg, Maryland 3 7/21/2014 Virtual/ numerical phantom for modeling clinical tumors Adele Peskin, Alden Dima, Charles Fenimore, James Filliben, Joseph Chen, Richard Rivello (Information Technology Laboratory) Realistic CT lung tumor data (virtual phantom) with known tumor volumes based on clinical tumors Embed synthetic tumors in DICOM data sets from NCI RIDER at two time points to determine accuracy of volume change measurements Tumor + blood vessels NV lung tissue Clinical tumor vascular/ partial volume Synthetic tumor Pixel value (Hounsfield units) Peskin Lecture Notes in Computer Science (LNCS) series pp. 736 - 746 2010 NIST/ISMRM MRI System Phantom First MRI phantom with NIST traceability, temperature and field corrections, stability monitoring Measures: • Geometric distortion, B1 uniformity, B0 uniformity, T1, T2, Proton density, resolution, slice thickness, SNR Purpose: Scanner QC and inter-scanner comparison, verify T1 T2 mapping protocols, off-the-shelf validation for some clinical trials MRI Phantoms: must cover large parameter space 1000 PVP 10% T2-T1 plot @ 1.5T for: NiCl2 & MnCl2 array @ 20C T1 Array 25% and selection of tissues @ 37 C T2 Array 40% Skin T2 (ms) Fiducial Array CSF Blood NiCl2 array PD Array Fibroglandular mimic MnCl2 array Gray matter 100 Fat Fat mimic Olive oil Heavy mineral oil White Matter Connective Glial Matter Optic nerve Spinal cord White matter Kidney Kidney Cartilage 55° Muscle Liver Skeletal muscle Liver Heart Cartilage 0° contrast enhanced 10 100 1000 • Phantoms contain materials with well defined parameters! • Many other dimensions required to mimic tissue: diffusion, conductivity, susceptibility! T1(ms) 4 7/21/2014 T1-Inversion Recovery gold standard: Need to understand variability 0.65 NiCl2 @ 1.5 T 20 0.64 Error = 100*(T1measured-T1)/T1 r1 (1/s) 0.63 0.62 15 5% 0.61 10 0.60 0.58 0.57 17 18 19 20 21 22 23 24 25 26 27 28 Temperature (C) • Arrays have large ranges with short and long T1s, T2s that can be challenging to measure • Need in-situ thermometry for accurate phantom measurement comparisons. Error (%) 0.59 NIST 1.5 T 20.12 C 11TI MDACC 1.5T-11TI MGH 1.5T-12TI Cin 1.5T-6TI MGH 3TB6-11TI MGH 3TB4-10TI CUINC3T-9TI UCD BIC 3T-10TI 5 0 -5 -10 -15 -20 10 272.9 4.1 ms CoV=1.5% 100 1000 Target T1 relaxation time (ms) Katy Keenan T1 Variable Flip Angle: Large variations in practical mapping sequences NIST/ISMRM system phantom T1 array Standard protocol: 7 flip angles Katy Keenan NIST/UCSF Universal Breast Phantom Katy Keenan NIST, Nola Hilton UCSF normal benign malignant • For ACRIN 6698/ISPY 2 DWI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment • T1, diffusion, geometric distortion, and tissue mimics 5 7/21/2014 T2 of olive oil used in breast phantom CPMG (NMR) SE (NMR/MRI) FSE (MRI) signal Do precise measurements of NMR parameters make sense in tissue? TE (s) Many peaks each with its own T1, T2 MRI measures apparent T1, apparent T2 and apparent diffusion coefficient! Need pragmatic but rigorous definitions? Mike Boss Breast Phantom: T2 ground truth? Spin echo includes chemical exchange r2 Dw2 B02 1.5 T 3.0 T MRI MultiEcho Spin Echo NMR CPMG* t = 1.0ms NMR MultiEcho Spin Echo* TE=15ms 2.26 mM NiCl2 & 0.25 mM MnCl2 in water 55 ms 57.8 ms 39.0 ms 38.8 ms 35% w/w Corn Syrup in water 261 ms 266 ms 47.3 ms 84.7 ms 40 ms 160 ms 32.5 ms 171.8 ms Material Grapeseed Oil NMR CPMG* MRI measurements at 16.5 deg C. NMR measurements at ~20 deg C. * Integrated over all peaks Mike Boss/ Katy Keenan SI traceability for MRI? PET dose calibrator •Traceability in MRI not established (exception dimensional traceability through optical interferometry) directly traceability to NIST •composition traceability for Ni and Mn concentrations NIST Nickel SRM 3136 and Manganese SRM 3132 Standard Solutions using inductively coupled plasma optical emission spectroscopy (ICPOES). • NIST can offer traceable measurements of T1, T2, ADC, susceptibility … using calibrated variable field, variable temperature NMR , magnetometry if we can agree on suitable definitions! System phantom reference libraries phantom reference libraries 6 7/21/2014 NIST Perspective/ Goals • NIST is ramping up biomedical imaging standards for quantitative biomarkers • Goal: extend precise traceable measurements inside the human • Assist developing/ validation MR phantoms: anisotropic diffusion, active flow/perfusion • NIST will help facilitate a roadmap for standards for quantitative MR • NIST will investigate a study of economic impact of standards-based quantitative MR Workshop on Standards for Quantitative MR NIST Boulder July, 2014 NIST MRI standards team: Mike Boss, Katy Keenan, Karl Stupic 7